Search research articles
Contact Us
Filters
Showing results (141-150 of 188) with videos related to
Page
of 19
Sort By:
Genomics
|
May 1, 1997
A 1.7-megabase sequence-ready cosmid contig covering the TSC1 candidate region in 9q34
N Hornigold, M van Slegtenhorst, J Nahmias, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 10, 2017
Deficits of ankle muscle strength not found in children, adolescents and young adults with haemophilic ankle arthropathy
S Lobet, J-L Croisier, A-C Lantin, et al.
Der Anaesthesist
|
February 1, 1980
Thalamonal, droperidol and fentanyl in induced hypovolaemic shock in the conscious dog
F L De Bie, P François, C Hermans, et al.
Orphanet Journal of Rare Diseases
|
August 25, 2020
European principles of inhibitor management in patients with haemophilia: implications of new treatment options
C Hermans, P L F Giangrande, B O'Mahony, et al.
Occupational and Environmental Medicine
|
May 29, 2003
Lung hyperpermeability and asthma prevalence in schoolchildren: unexpected associations with the attendance at indoor chlorinated swimming pools
A Bernard, S Carbonnelle, O Michel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2011
Recommendations for assessment, monitoring and follow-up of patients with haemophilia
P de Moerloose, K Fischer, T Lambert, et al.
International Journal of Clinical Practice
|
December 16, 2010
Antihypertensive effectiveness of aliskiren for the 'real-world' management of hypertension: multilevel modelling of 180-day blood pressure outcomes (the Belgian DRIVER Study)
G A Verpooten, A Aerts, N Coen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer
C Dittrich, B Coudert, L Paz-Ares, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 16, 2009
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
C Hermans, C Altisent, A Batorova, et al.
Colloids and Surfaces. B, Biointerfaces
|
December 4, 2014
Melittin disruption of raft and non-raft-forming biomimetic membranes: a study by quartz crystal microbalance with dissipation monitoring
P Losada-Pérez, M Khorshid, C Hermans, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 188) with videos related to
Sort By:
Page
of 19
Genomics
|
May 1, 1997
A 1.7-megabase sequence-ready cosmid contig covering the TSC1 candidate region in 9q34
N Hornigold, M van Slegtenhorst, J Nahmias, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 10, 2017
Deficits of ankle muscle strength not found in children, adolescents and young adults with haemophilic ankle arthropathy
S Lobet, J-L Croisier, A-C Lantin, et al.
Der Anaesthesist
|
February 1, 1980
Thalamonal, droperidol and fentanyl in induced hypovolaemic shock in the conscious dog
F L De Bie, P François, C Hermans, et al.
Orphanet Journal of Rare Diseases
|
August 25, 2020
European principles of inhibitor management in patients with haemophilia: implications of new treatment options
C Hermans, P L F Giangrande, B O'Mahony, et al.
Occupational and Environmental Medicine
|
May 29, 2003
Lung hyperpermeability and asthma prevalence in schoolchildren: unexpected associations with the attendance at indoor chlorinated swimming pools
A Bernard, S Carbonnelle, O Michel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2011
Recommendations for assessment, monitoring and follow-up of patients with haemophilia
P de Moerloose, K Fischer, T Lambert, et al.
International Journal of Clinical Practice
|
December 16, 2010
Antihypertensive effectiveness of aliskiren for the 'real-world' management of hypertension: multilevel modelling of 180-day blood pressure outcomes (the Belgian DRIVER Study)
G A Verpooten, A Aerts, N Coen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer
C Dittrich, B Coudert, L Paz-Ares, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 16, 2009
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
C Hermans, C Altisent, A Batorova, et al.
Colloids and Surfaces. B, Biointerfaces
|
December 4, 2014
Melittin disruption of raft and non-raft-forming biomimetic membranes: a study by quartz crystal microbalance with dissipation monitoring
P Losada-Pérez, M Khorshid, C Hermans, et al.
Page
of 19